Aclaris Therapeutics, Inc. (ACRS) Financials

ACRS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 198.7 million 55.1 million
Dec. 31, 2025 160.5 million 57.4 million
Sept. 30, 2025 175.5 million 55.4 million
June 30, 2025 189.1 million 57.4 million

ACRS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -18.1 million 3.2 million
Dec. 31, 2025 -13.2 million 2.9 million
Sept. 30, 2025 -11.0 million 2.9 million
June 30, 2025 -10.0 million 3.1 million

ACRS Net Income

No data available :(

ACRS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 105.4 million - 1.4 million
Dec. 31, 2025 90.8 million - 1.6 million
Sept. 30, 2025 95.9 million - 1.7 million
June 30, 2025 99.8 million - -

ACRS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 128.8 million
Dec. 31, 2025 122.7 million
Sept. 30, 2025 122.6 million
June 30, 2025 122.6 million

ACRS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 13000 15.7 million 6.7 million -
Dec. 31, 2025 24000 16.6 million 5.6 million -
Sept. 30, 2025 23000 13.0 million 4.9 million -
June 30, 2025 21000 11.4 million 5.4 million -

ACRS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.0 million 395000
Dec. 31, 2025 1.3 million -803000
Sept. 30, 2025 3.3 million 538000
June 30, 2025 1.8 million 1.9 million

ACRS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ACRS

Price: $4.42

52 week price:
1.34
5.15

Earnings Per Share: -0.56 USD

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 2.0 million

Ebitda: -18.6 million

Market Capitalization: 533.0 million

Links: